Viagra is an erectile dysfunction drug manufactured by Pfizer. In 2014, a study found an 84% increased risk of melanoma (skin cancer) associated with Viagra. Other studies suggest it may increase the risk of vision problems, including blindness.
UPDATE: Viagra Lawsuits Centralized in MDL
April 2016 — Federal judges have centralized all federal Viagra lawsuits involving melanoma (skin cancer) into a Multi-District Litigation (MDL No. 2691) in the U.S. District Court for the Northern District of California under Judge Richard Seeborg:
- IN RE: Viagra (Sildenafil Citrate) Products Liability Litigation, Multi-District Litigation (MDL No. 2691)
Study Finds 84% Increased Risk
In June 2014, JAMA Internal Medicine published a study linking the use of Viagra (sildenafil) to an 84% increased risk of melanoma (skin cancer). Conclusions were based on data from nearly 26,000 men who participated in a study at the Harvard School of Public Health. Click here to read more.
Study Links Viagra and Melanoma
A study has found that men who take Viagra are 21% more likely to develop malignant melanoma (aggressive skin cancer), but researchers believe the increased risk is due to lifestyle factors and not a causal relationship between the drug and disease. Click here to read more.
Study Links Viagra and Risk of Vision Loss
Pfizer’s blockbuster erectile dysfunction drug Viagra is already known to cause vision problems, but a study published in October 2014 suggests that people with a common gene mutation might be at risk of permanent vision loss. Click here to read more.